Use of chromatin immunoprecipitation to clone novel E2F target promoters

A. S. Weinmann, S. M. Bartley, T. Zhang, M. Q. Zhang, P. J. Farnham

Research output: Contribution to journalArticle

323 Citations (Scopus)

Abstract

We have taken a new approach to the identification of E2F-regulated promoters. After modification of a chromatin immunoprecipitation assay, we cloned nine chromatin fragments which represent both strong and weak in vivo E2F binding sites. Further characterization of three of the cloned fragments revealed that they are bound in vivo not only by E2Fs but also by members of the retinoblastoma tumor suppressor protein family and by RNA polymerase II, suggesting that these fragments represent promoters regulated by E2F transcription complexes. In fact, database analysis indicates that all three fragments correspond to genomic DNA located just upstream of start sites for previously identified mRNAs. One clone, ChET 4, corresponds to the promoter region for beclin 1, a candidate tumor suppressor protein. We demonstrate that another of the clones, ChET 8, is strongly bound by E2F family members in vivo but does not contain a consensus E2F binding site. However, this fragment functions as a promoter whose activity can be repressed by E2FL Finally, we demonstrate that the ChET 9 promoter contains a consensus E2F binding site, can be activated by E2F1, and drives expression of an mRNA that is upregulated in colon and liver tumors. Interestingly, the characterized ChET promoters do not display regulation patterns typical of known E2F target genes in a U937 cell differentiation system. In summary, we have provided evidence that chromatin immunoprecipitation can be used to identify E2F-regulated promoters which contain both consensus and nonconsensus binding sites and have shown that not all E2F-regulated promoters show identical expression profiles.

Original languageEnglish (US)
Pages (from-to)6820-6832
Number of pages13
JournalMolecular and Cellular Biology
Volume21
Issue number20
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Chromatin Immunoprecipitation
Clone Cells
Binding Sites
Tumor Suppressor Proteins
Consensus
Retinoblastoma Protein
U937 Cells
Messenger RNA
RNA Polymerase II
Genetic Promoter Regions
Chromatin
Cell Differentiation
Colon
Databases
Liver
DNA
Genes
Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. J. (2001). Use of chromatin immunoprecipitation to clone novel E2F target promoters. Molecular and Cellular Biology, 21(20), 6820-6832. https://doi.org/10.1128/MCB.21.20.6820-6832.2001

Use of chromatin immunoprecipitation to clone novel E2F target promoters. / Weinmann, A. S.; Bartley, S. M.; Zhang, T.; Zhang, M. Q.; Farnham, P. J.

In: Molecular and Cellular Biology, Vol. 21, No. 20, 2001, p. 6820-6832.

Research output: Contribution to journalArticle

Weinmann, AS, Bartley, SM, Zhang, T, Zhang, MQ & Farnham, PJ 2001, 'Use of chromatin immunoprecipitation to clone novel E2F target promoters', Molecular and Cellular Biology, vol. 21, no. 20, pp. 6820-6832. https://doi.org/10.1128/MCB.21.20.6820-6832.2001
Weinmann, A. S. ; Bartley, S. M. ; Zhang, T. ; Zhang, M. Q. ; Farnham, P. J. / Use of chromatin immunoprecipitation to clone novel E2F target promoters. In: Molecular and Cellular Biology. 2001 ; Vol. 21, No. 20. pp. 6820-6832.
@article{d752915f0d424ea8816687ba36f13518,
title = "Use of chromatin immunoprecipitation to clone novel E2F target promoters",
abstract = "We have taken a new approach to the identification of E2F-regulated promoters. After modification of a chromatin immunoprecipitation assay, we cloned nine chromatin fragments which represent both strong and weak in vivo E2F binding sites. Further characterization of three of the cloned fragments revealed that they are bound in vivo not only by E2Fs but also by members of the retinoblastoma tumor suppressor protein family and by RNA polymerase II, suggesting that these fragments represent promoters regulated by E2F transcription complexes. In fact, database analysis indicates that all three fragments correspond to genomic DNA located just upstream of start sites for previously identified mRNAs. One clone, ChET 4, corresponds to the promoter region for beclin 1, a candidate tumor suppressor protein. We demonstrate that another of the clones, ChET 8, is strongly bound by E2F family members in vivo but does not contain a consensus E2F binding site. However, this fragment functions as a promoter whose activity can be repressed by E2FL Finally, we demonstrate that the ChET 9 promoter contains a consensus E2F binding site, can be activated by E2F1, and drives expression of an mRNA that is upregulated in colon and liver tumors. Interestingly, the characterized ChET promoters do not display regulation patterns typical of known E2F target genes in a U937 cell differentiation system. In summary, we have provided evidence that chromatin immunoprecipitation can be used to identify E2F-regulated promoters which contain both consensus and nonconsensus binding sites and have shown that not all E2F-regulated promoters show identical expression profiles.",
author = "Weinmann, {A. S.} and Bartley, {S. M.} and T. Zhang and Zhang, {M. Q.} and Farnham, {P. J.}",
year = "2001",
doi = "10.1128/MCB.21.20.6820-6832.2001",
language = "English (US)",
volume = "21",
pages = "6820--6832",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "20",

}

TY - JOUR

T1 - Use of chromatin immunoprecipitation to clone novel E2F target promoters

AU - Weinmann, A. S.

AU - Bartley, S. M.

AU - Zhang, T.

AU - Zhang, M. Q.

AU - Farnham, P. J.

PY - 2001

Y1 - 2001

N2 - We have taken a new approach to the identification of E2F-regulated promoters. After modification of a chromatin immunoprecipitation assay, we cloned nine chromatin fragments which represent both strong and weak in vivo E2F binding sites. Further characterization of three of the cloned fragments revealed that they are bound in vivo not only by E2Fs but also by members of the retinoblastoma tumor suppressor protein family and by RNA polymerase II, suggesting that these fragments represent promoters regulated by E2F transcription complexes. In fact, database analysis indicates that all three fragments correspond to genomic DNA located just upstream of start sites for previously identified mRNAs. One clone, ChET 4, corresponds to the promoter region for beclin 1, a candidate tumor suppressor protein. We demonstrate that another of the clones, ChET 8, is strongly bound by E2F family members in vivo but does not contain a consensus E2F binding site. However, this fragment functions as a promoter whose activity can be repressed by E2FL Finally, we demonstrate that the ChET 9 promoter contains a consensus E2F binding site, can be activated by E2F1, and drives expression of an mRNA that is upregulated in colon and liver tumors. Interestingly, the characterized ChET promoters do not display regulation patterns typical of known E2F target genes in a U937 cell differentiation system. In summary, we have provided evidence that chromatin immunoprecipitation can be used to identify E2F-regulated promoters which contain both consensus and nonconsensus binding sites and have shown that not all E2F-regulated promoters show identical expression profiles.

AB - We have taken a new approach to the identification of E2F-regulated promoters. After modification of a chromatin immunoprecipitation assay, we cloned nine chromatin fragments which represent both strong and weak in vivo E2F binding sites. Further characterization of three of the cloned fragments revealed that they are bound in vivo not only by E2Fs but also by members of the retinoblastoma tumor suppressor protein family and by RNA polymerase II, suggesting that these fragments represent promoters regulated by E2F transcription complexes. In fact, database analysis indicates that all three fragments correspond to genomic DNA located just upstream of start sites for previously identified mRNAs. One clone, ChET 4, corresponds to the promoter region for beclin 1, a candidate tumor suppressor protein. We demonstrate that another of the clones, ChET 8, is strongly bound by E2F family members in vivo but does not contain a consensus E2F binding site. However, this fragment functions as a promoter whose activity can be repressed by E2FL Finally, we demonstrate that the ChET 9 promoter contains a consensus E2F binding site, can be activated by E2F1, and drives expression of an mRNA that is upregulated in colon and liver tumors. Interestingly, the characterized ChET promoters do not display regulation patterns typical of known E2F target genes in a U937 cell differentiation system. In summary, we have provided evidence that chromatin immunoprecipitation can be used to identify E2F-regulated promoters which contain both consensus and nonconsensus binding sites and have shown that not all E2F-regulated promoters show identical expression profiles.

UR - http://www.scopus.com/inward/record.url?scp=0034802618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034802618&partnerID=8YFLogxK

U2 - 10.1128/MCB.21.20.6820-6832.2001

DO - 10.1128/MCB.21.20.6820-6832.2001

M3 - Article

C2 - 11564866

AN - SCOPUS:0034802618

VL - 21

SP - 6820

EP - 6832

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 20

ER -